리라글루티드 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 8.6%의 CAGR로 96억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 보험 및 상환 정책의 증가, 의료 인프라 개발, 인식 및 교육 이니셔티브의 증가, 고령화 인구 증가, 당뇨병 유병률 증가 등에 기인하는 것으로 추정됩니다. 예측 기간 동안 주요 동향으로는 인공지능 및 머신러닝 활용, 웨어러블 기술 수요, 연속 혈당 모니터링의 통합, 바이오테크놀러지의 발전, 디지털 헬스 플랫폼의 개발 등이 있습니다.
당뇨병 인구의 증가는 향후 몇 년 동안 리라글루티드 시장의 성장을 촉진할 것으로 예상됩니다. 당뇨병은 인슐린 분비가 불충분하거나 인슐린 이용이 효율적이지 않아 신체가 혈당을 효과적으로 조절하는 데 어려움을 겪는 장기적인 상태입니다. 당뇨병의 유병률은 좌식 생활습관, 식습관 장애, 전 세계 비만율 증가 등의 요인으로 인해 증가하고 있습니다. 리라글루티드와 같은 당뇨병 치료제는 인슐린 분비를 촉진하고 혈당을 낮추며 체중 감소를 돕는 호르몬 GLP-1의 작용을 모방하여 제2형 당뇨병 관리를 돕습니다. 예를 들어, 2024년 3월 영국 정부의 보고서에 따르면, 2023년 3월 영국에서 1형 당뇨병 환자가 NDA 참여 GP 진료소에서 8가지 치료 과정을 모두 받은 비율은 전년도 35.2%에서 43.8%로 상승했습니다. 따라서 당뇨병 인구의 증가가 리라글루티드 시장의 성장을 주도하고 있습니다.
리라글루티드 시장의 주요 업체들은 제네릭 GLP-1과 같은 혁신적인 제품을 개발하여 치료 선택의 폭을 넓히고 보다 저렴한 대안에 대한 수요를 충족시키고 있습니다. 제네릭 GLP-1은 GLP-1 수용체 작용제의 특허가 만료된 후 생산되는 제품으로, 제2형 당뇨병과 비만 등의 치료에 비용 효율적인 대안을 제공합니다. 예를 들어, 이스라엘에 본사를 둔 제약사 테바 파마슈티컬 인더스트리즈(Teva Pharmaceutical Industries)는 2024년 6월 빅토자와 유사한 최초의 GLP-1 제네릭 의약품을 미국 시장에 출시하여 이러한 치료제에 대한 수요 증가에 대응하고 있습니다. 리라글루티드 주사는 10세 이상의 성인 및 소아 제2형 당뇨병 환자의 혈당 조절 개선과 제2형 당뇨병 및 기존 심혈관질환을 앓고 있는 성인의 심혈관계 질환 위험 감소를 목적으로 처방됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 리라글루티드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 리라글루티드 시장 : 성장률 분석
- 세계의 리라글루티드 시장 실적 : 규모와 성장, 2019-2024
- 세계의 리라글루티드 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 리라글루티드 전체 시장(TAM)
제6장 시장 세분화
- 세계의 리라글루티드 시장 : 브랜드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Victoza
- Saxenda
- 세계의 리라글루티드 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국과 드럭스토어
- 온라인 약국
- 세계의 리라글루티드 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 당뇨병 치료
- 체중 관리
- 세계의 리라글루티드 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원과 진료소
- 재택 케어 설정
- 세계의 리라글루티드 시장, Victoza 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 2형 당뇨병 치료
- 체중 관리
- 세계의 리라글루티드 시장, Saxenda 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 감량 치료
- 비만 관리
제7장 지역별·국가별 분석
- 세계의 리라글루티드 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 리라글루티드 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 리라글루티드 시장 : 경쟁 구도
- 리라글루티드 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Novartis International AG
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- Novo Nordisk A/S
- Teva Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- Biocon Limited
- Hanmi Pharmaceutical Co. Ltd.
- Intarcia Therapeutics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 리라글루티드 시장 2029 : 새로운 기회를 제공하는 국가
- 리라글루티드 시장 2029 : 새로운 기회를 제공하는 부문
- 리라글루티드 시장 2029 : 성장 전략
제36장 부록
ksm
Liraglutide is a GLP-1 receptor agonist utilized for managing type 2 diabetes and obesity. It lowers blood sugar levels and encourages weight loss by imitating the incretin hormone GLP-1. Given through subcutaneous injection, it boosts insulin secretion and curbs appetite. Liraglutide is available under the brand names Victoza for diabetes and Saxenda for obesity.
The primary brands of liraglutide are Victoza and Saxenda. Victoza is a brand name for liraglutide, a medication prescribed for type 2 diabetes. It can be obtained from hospital pharmacies, retail pharmacies, drug stores, and online pharmacies, and is used for managing diabetes and weight. It is utilized by different end-users, such as hospitals, clinics, and home care settings.
The liraglutide market research report is one of a series of new reports from The Business Research Company that provides liraglutide market statistics, including liraglutide industry global market size, regional shares, competitors with a liraglutide market share, detailed liraglutide market segments, market trends and opportunities, and any further data you may need to thrive in the liraglutide industry. This liraglutide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The liraglutide market size has grown strongly in recent years. It will grow from $6.38 billion in 2024 to $6.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the increasing number of people diagnosed with type 2 diabetes, growing obesity rates, extensive clinical trials, growing awareness of diabetes complications, and rising innovations in drug delivery systems.
The liraglutide market size is expected to see strong growth in the next few years. It will grow to $9.66 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing insurance and reimbursement policies, healthcare infrastructure development, increasing awareness and educational initiatives, a growing aging population, and the increasing prevalence of diabetes. Major trends in the forecast period include the use of artificial intelligence and machine learning, demand for wearable technology, continuous glucose monitoring integration, biotechnology advancements, and the development of digital health platforms.
The growing diabetic population is anticipated to drive the expansion of the liraglutide market in the coming years. Diabetes is a long-term condition in which the body struggles to regulate blood sugar levels effectively, either due to inadequate insulin production or ineffective insulin utilization. The prevalence of diabetes is rising due to factors such as sedentary lifestyles, poor dietary habits, and increasing obesity rates globally. Diabetes medications like liraglutide aid in managing type 2 diabetes by mimicking the effects of the hormone GLP-1, which enhances insulin release, reduces blood sugar levels, and supports weight loss. For example, in March 2024, a report by the Government of the United Kingdom indicated that in March 2023, the proportion of individuals with type 1 diabetes in England receiving all 8 care processes at participating GP practices in the NDA rose to 43.8%, up from 35.2% the previous year. Therefore, the rising diabetic population is driving the growth of the liraglutide market.
Leading companies in the liraglutide market are creating innovative products, such as generic GLP-1, to broaden treatment options and meet the demand for more affordable alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists produced after the original branded medications' patent protection has expired, providing cost-effective options for treating conditions such as type 2 diabetes and obesity. For example, in June 2024, Teva Pharmaceutical Industries Ltd., a pharmaceutical company based in Israel, launched the first generic GLP-1 similar to Victoza in the U.S. market, addressing the growing need for these therapies. Liraglutide injections are prescribed to improve blood sugar management in adults and children aged 10 and older with type 2 diabetes and to reduce the risk of cardiovascular events in adults with type 2 diabetes and existing cardiovascular conditions.
In October 2023, Biocon Limited, a biopharmaceutical company based in India, entered into a partnership with Juno Pharmaceuticals to commercialize its vertically integrated, complex formulation, Liraglutide. According to the terms of the agreement, Biocon will handle the regulatory approval process for Liraglutide and will subsequently manage the manufacturing and supply of the product in the Canadian market. Juno Pharmaceuticals, a Canada-based pharmaceutical company, specializes in introducing complex and high-value generic and biosimilar products to the market.
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA
North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the liraglutide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The liraglutide market consists of sales of insulin products, weight management supplements, nutritional supplements, and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liraglutide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on liraglutide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for liraglutide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liraglutide market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Brands: Victoza; Saxenda
- 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Drug Stores; Online Pharmacies
- 3) By Type Of Application: Diabetes Treatment; Weight Management
- 4) By End-Users: Hospitals And Clinics; Homecare Settings
- Subsegments:
- 1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
- 2) By Saxenda: Weight Loss Treatment Or Obesity Management
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Liraglutide Market Characteristics
3. Liraglutide Market Trends And Strategies
4. Liraglutide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Liraglutide Growth Analysis And Strategic Analysis Framework
- 5.1. Global Liraglutide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Liraglutide Market Growth Rate Analysis
- 5.4. Global Liraglutide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Liraglutide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Liraglutide Total Addressable Market (TAM)
6. Liraglutide Market Segmentation
- 6.1. Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Victoza
- Saxenda
- 6.2. Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies And Drug Stores
- Online Pharmacies
- 6.3. Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diabetes Treatment
- Weight Management
- 6.4. Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Homecare Settings
- 6.5. Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Type 2 Diabetes Treatment
- Weight Management
- 6.6. Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Weight Loss Treatment
- Obesity Management
7. Liraglutide Market Regional And Country Analysis
- 7.1. Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Liraglutide Market
- 8.1. Asia-Pacific Liraglutide Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Liraglutide Market
- 9.1. China Liraglutide Market Overview
- 9.2. China Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Liraglutide Market
- 10.1. India Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Liraglutide Market
- 11.1. Japan Liraglutide Market Overview
- 11.2. Japan Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Liraglutide Market
- 12.1. Australia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Liraglutide Market
- 13.1. Indonesia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Liraglutide Market
- 14.1. South Korea Liraglutide Market Overview
- 14.2. South Korea Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Liraglutide Market
- 15.1. Western Europe Liraglutide Market Overview
- 15.2. Western Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Liraglutide Market
- 16.1. UK Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Liraglutide Market
- 17.1. Germany Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Liraglutide Market
- 18.1. France Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Liraglutide Market
- 19.1. Italy Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Liraglutide Market
- 20.1. Spain Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Liraglutide Market
- 21.1. Eastern Europe Liraglutide Market Overview
- 21.2. Eastern Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Liraglutide Market
- 22.1. Russia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Liraglutide Market
- 23.1. North America Liraglutide Market Overview
- 23.2. North America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Liraglutide Market
- 24.1. USA Liraglutide Market Overview
- 24.2. USA Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Liraglutide Market
- 25.1. Canada Liraglutide Market Overview
- 25.2. Canada Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Liraglutide Market
- 26.1. South America Liraglutide Market Overview
- 26.2. South America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Liraglutide Market
- 27.1. Brazil Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Liraglutide Market
- 28.1. Middle East Liraglutide Market Overview
- 28.2. Middle East Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Liraglutide Market
- 29.1. Africa Liraglutide Market Overview
- 29.2. Africa Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Liraglutide Market Competitive Landscape And Company Profiles
- 30.1. Liraglutide Market Competitive Landscape
- 30.2. Liraglutide Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Liraglutide Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb Company
- 31.2. AstraZeneca PLC
- 31.3. Novartis International AG
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. GlaxoSmithKline Plc
- 31.6. Eli Lilly and Company
- 31.7. Amgen Inc.
- 31.8. Boehringer Ingelheim International GmbH
- 31.9. Novo Nordisk A/S
- 31.10. Teva Pharmaceutical Industries Ltd.
- 31.11. Cipla Limited
- 31.12. Dr. Reddy's Laboratories Ltd.
- 31.13. Biocon Limited
- 31.14. Hanmi Pharmaceutical Co. Ltd.
- 31.15. Intarcia Therapeutics Inc.
32. Global Liraglutide Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Liraglutide Market
34. Recent Developments In The Liraglutide Market
35. Liraglutide Market High Potential Countries, Segments and Strategies
- 35.1 Liraglutide Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Liraglutide Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Liraglutide Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
